This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 26/8/1864    most recent 01.ATV.0000229659.94020.53v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by López-Franco, O. Articles by Gómez-Guerrero, C. Search for Related Content PubMed PubMed Citation Articles by López-Franco, O. Articles by Gómez-Guerrero, C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Animal models of human disease Cell signalling/signal transduction Growth factors/cytokines

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1864.)
© 2006 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Parthenolide Modulates the NF-B–Mediated Inflammatory Responses in Experimental Atherosclerosis

Oscar López-Franco; Purificación Hernández-Vargas; Guadalupe Ortiz-Muñoz; Guillermo Sanjuán; Yusuke Suzuki; Luis Ortega; Julia Blanco; Jesús Egido; Carmen Gómez-Guerrero

From the Renal and Vascular Research Laboratory (O.L.-F., P.H.-V., G.O.-M., G.S., J.E., C.G.-G.), Fundación Jiménez Díaz, Autónoma University, Madrid, Spain; the Division of Nephrology, Department of Internal Medicine (Y.S.), Juntendo University School of Medicine, Tokyo, Japan; and the Hospital Clínico San Carlos (L.O., J.B.), Complutense University, Madrid, Spain.

Correspondence to Carmen Gómez-Guerrero, PhD, Renal and Vascular Research Lab, Fundación Jiménez Díaz (Autónoma University), Avda. Reyes Católicos, 2 28040 Madrid, Spain. E-mail cgomez{at}fjd.es

Objective— Activation of transcription factor NF-B is an important step in the development of vascular damage, because it controls inducible genes, including many inflammatory mediators. The pharmacological modulation of this process is the main objective in the design of new therapies for atherosclerosis. In this work we analyzed the effects of the natural compound parthenolide (PTN), an NF-B inhibitor.

Methods and Results— In vascular smooth muscle cells (VSMCs) and monocytes stimulated with lipopolysaccharide (LPS), nontoxic doses of PTN reduced IB degradation, NF-B activation, and MCP-1 expression, without inhibiting AP-1 and MAPK. In apoE mice, treatment with low (2 mg/kg, 20 weeks), medium (4 mg/kg, 10 weeks), and high (10 mg/kg, 10 weeks) dose of PTN reduced the size of aortic lesion, decreased macrophage, and increased VSMC content in the lesions. Treated mice showed reduced serum levels of MCP-1 and attenuated NF-B activity, but not AP-1, in the lesions. Moreover, PTN affects neither apoptotic cell death nor oxidative stress in cultured cells and mice.

Conclusion— NF-B inhibition by PTN retards atherosclerotic lesions in apoE mice, by reducing lesion size and changing plaque composition. This natural compound could represent a novel therapeutic approach to inflammation during vascular damage.

PTN inhibits the NF-B activation and expression of regulated genes in cultured VSMCs and monocytes. PTN protects against the development of atherosclerosis in apoE mice by inhibition of NF-B and reduction of inflammatory cell infiltration. PTN treatment may represent a novel therapeutic approach to atherosclerosis.

Key Words: NF-B • atherosclerosis • parthenolide • apoE • inflammation

This article has been cited by other articles:

				R. Largo, M. J. Martinez-Calatrava, O. Sanchez-Pernaute, M. E. Marcos, J. Moreno-Rubio, C. Aparicio, J. Egido, and G. Herrero-Beaumont Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H268 - H276. [Abstract] [Full Text] [PDF]

				G. Ortiz-Munoz, J. L. Martin-Ventura, P. Hernandez-Vargas, B. Mallavia, V. Lopez-Parra, O. Lopez-Franco, B. Munoz-Garcia, P. Fernandez-Vizarra, L. Ortega, J. Egido, et al. Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 525 - 531. [Abstract] [Full Text] [PDF]

				B. You, Y.-Y. Jiang, S. Chen, G. Yan, and J. Sun The Orphan Nuclear Receptor Nur77 Suppresses Endothelial Cell Activation Through Induction of I{kappa}B{alpha} Expression Circ. Res., March 27, 2009; 104(6): 742 - 749. [Abstract] [Full Text] [PDF]

				C. Cuaz-Perolin, L. Billiet, E. Bauge, C. Copin, D. Scott-Algara, F. Genze, B. Buchele, T. Syrovets, T. Simmet, and M. Rouis Antiinflammatory and Antiatherogenic Effects of the NF-{kappa}B Inhibitor Acetyl-11-Keto-{beta}-Boswellic Acid in LPS-Challenged ApoE-/- Mice Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 272 - 277. [Abstract] [Full Text] [PDF]

				P. Hernandez-Vargas, G. Ortiz-Munoz, O. Lopez-Franco, Y. Suzuki, J. Gallego-Delgado, G. Sanjuan, A. Lazaro, V. Lopez-Parra, L. Ortega, J. Egido, et al. Fc{gamma} Receptor Deficiency Confers Protection Against Atherosclerosis in Apolipoprotein E Knockout Mice Circ. Res., November 24, 2006; 99(11): 1188 - 1196. [Abstract] [Full Text] [PDF]